Clinical Relevance
Clinical Relevance - Related Videos
09:54
A Model to Simulate Clinically Relevant Hypoxia in Humans
0 Views •
Cited by 1 •
2016
Hypoxia simulation in humans has usually been performed by inhaling hypoxic gas mixtures. For this study, apneic divers were used to simulate dynamic hypoxia in humans. Additionally, physiological changes in desaturation and re-saturation kinetics were evaluated with non-invasive tools such as Near-Infrared-Spectroscopy (NIRS) and peripheral oxygenation saturation (SpO2).
01:29
Clinically Relevant Drug Product Specifications: Methods of Establishment
0 Views •
2025
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
08:14
Developing a Clinically Relevant Hemorrhagic Shock Model in Rats
0 Views •
Cited by 1 •
2024
Hemorrhagic shock kills 1.9 million people worldwide every year. Small animals are frequently used as hemorrhagic shock models but are associated with issues of standardization, reproducibility, and clinical significance, thus limiting their relevance. This article describes developing a new clinically relevant hemorrhagic shock model in rats.
08:46
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
0 Views •
Cited by 2 •
2015
Drug resistance to targeted therapeutics is widespread and the need to identify mechanisms of resistance--prior to or following clinical onset--is critical for guiding alternative clinical management strategies. Here, we present a protocol to couple derivation of drug-resistant lines in vitro with sequencing to expedite discovery of these mechanisms.
06:51
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
0 Views •
Cited by 53 •
2016
This protocol outlines the cefoperazone mouse model of Clostridium difficile infection (CDI) using a clinically-relevant and genetically-tractable strain, R20291. Emphasis on clinical disease monitoring, C. difficile bacterial enumeration, toxin cytotoxicity, and histopathological changes throughout CDI in a mouse model are detailed in the protocol.
FAQs
Pharmacokinetic properties help relate a drug to dosing decisions, while pharmacodynamic properties connect its action to therapeutic effects and adverse reactions. Considering both prevents interpretation based on mechanism alone. Their combined evaluation helps determine whether a laboratory or study finding is likely to support useful treatment, acceptable safety, and appropriate dosing in real patients.
A result can be statistically significant without producing a meaningful improvement in patient care. Clinical relevance therefore asks whether a finding improves symptom control, reduces disease risk, or changes safety in a worthwhile way. This distinction helps pharmacologists and clinicians prioritize outcomes that matter to patients rather than treating numerical significance as proof of practical benefit.
The therapeutic window helps frame the balance between beneficial effects and harmful effects. A clinically relevant assessment considers whether dosing can achieve therapeutic effects while limiting adverse reactions. This perspective links pharmacological findings to safer prescribing and helps determine whether a drug’s observed activity is usable in patient care rather than merely demonstrable under study conditions.
Findings should be considered in relation to diverse patient populations, because a treatment result must translate beyond a single experimental setting to have broad practical value. Pharmacology uses this perspective when interpreting effects, dosing decisions, safety, and adverse reactions. It supports evaluation of whether evidence can guide care for patients who may not respond identically.
Researchers can first relate the drug’s mechanism to its pharmacokinetic and pharmacodynamic properties, then examine therapeutic effects, dosing decisions, safety, and adverse reactions. They should also ask whether the findings improve symptom control or reduce disease risk. This sequence separates biologically interesting results from evidence that can support prescribing or further medicine development.
Clinical relevance is central when deciding whether study findings justify therapeutic use, dose selection, or additional development. It guides evidence-based prescribing by weighing benefits against safety concerns, therapeutic limits, and drug interactions. The same perspective supports development of medicines that are not only pharmacologically active, but also more effective and safer for real patients.